Abstract
Aim of the studyTo evaluate the efficacy of the combined use of both transarterial chemoembolization (TACE) and percutaneous radiofrequency ablation (RFA) in a single session for the treatment of large (≥3 cm in diameter) hepatocellular carcinoma. Patients and methodsThis study was carried out on 30 patients (23 males and 7 females, with age range between 46 and 74 years), with either solitary or multiple hepatocellular carcinomas. Every patient was subjected to a single-session combined RFA with TACE. Targeting the lesion with RFA needle was first done, to secure its access into the lesion, under ultrasound guidance. Super-selective TACE was then performed, followed by the RFA procedure. ResultsOne-month follow-up revealed complete ablation of the tumour in 25 patients (83.3%), while 5 patients (16.7%) showed residual tumour activity, requiring an additional TACE session. No major complications related to the procedure were recorded during the duration of this study. The probability of encountering, both intra- and post-procedural, minor complications was significantly higher with large focal lesion diameters (P = .039 and .003, respectively). ConclusionSingle-session combined TACE and RFA is a safe and effective treatment option for the control of large HCC lesions, with no major procedure-related complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Egyptian Journal of Radiology and Nuclear Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
